Actinic keratosis is a common skin condition caused by years of sun exposure that creates rough, scaly patches on areas like the face, scalp, hands, and arms. While these patches are not cancer themselves, they can sometimes develop into skin cancer if left untreated, making early diagnosis and proper care essential for protecting your skin’s health.

Understanding Treatment Goals for Sun-Damaged Skin

When you develop actinic keratosis, the main goal of treatment is to remove these precancerous patches before they have a chance to progress into something more serious. Treatment aims to eliminate visible lesions, prevent new ones from forming, and reduce the risk of developing squamous cell carcinoma, which is a type of skin cancer that can arise from untreated actinic keratoses.^[1] The approach to treatment depends heavily on how many patches you have, where they are located on your body, and your overall health situation.^[3]

Healthcare providers have established standard treatments that have proven effective over many years of use. These include both methods performed in the doctor’s office and medications you can apply at home. At the same time, researchers continue to explore new therapies through clinical trials, searching for treatments that might work better, cause fewer side effects, or address patches that haven’t responded to traditional approaches.^[11] The choice between different treatment options often considers factors like your age, whether you have just one patch or many scattered across your skin, your history with skin cancer, and how well you can tolerate the discomfort that some treatments may cause.^[14]

It’s important to understand that having actinic keratosis means your skin has accumulated damage from ultraviolet radiation over time. Even after successful treatment of existing patches, new ones can appear if your skin continues to be exposed to the sun without protection.^[6] This is why treatment plans typically combine removing current patches with strategies to prevent future ones, including rigorous sun protection measures.

Standard Medical Treatments

Medical professionals use several well-established approaches to treat actinic keratosis. If you have only one or a few isolated patches, your doctor might recommend surgical or procedural methods that can be performed during an office visit. These treatments work by physically destroying or removing the abnormal skin cells.^[9]

Cryotherapy, or freezing treatment, is one of the most commonly used procedures. During this treatment, your doctor applies liquid nitrogen directly to the affected skin. This extremely cold substance freezes the abnormal cells, causing them to die and eventually peel away.^[1] The procedure takes only a few minutes and can be done right in the office. After treatment, the area may blister and form a scab over several days before healing. While cryotherapy is effective and convenient, it can sometimes cause temporary changes in skin color or leave small scars, particularly in people with darker skin tones.^[9]

Another surgical option is curettage and desiccation, where the doctor first scrapes off the lesion using a special instrument called a curet, then applies heat or a chemical agent to destroy any remaining abnormal cells and stop bleeding.^[1] You’ll receive a local anesthetic before this procedure so you won’t feel pain during the treatment. Similar to cryotherapy, this method is particularly useful when you have just a few patches to remove.

For people who have many actinic keratoses spread across larger areas of skin, doctors often prescribe topical medications that you apply at home over several weeks. These medications work by targeting rapidly dividing cells, which includes the abnormal cells that make up actinic keratosis patches.^[14]

5-Fluorouracil, often shortened to 5-FU, is a cream or solution that has been used for decades to treat actinic keratosis. It works by interfering with the DNA synthesis in abnormal cells, preventing them from multiplying.^[14] The most common formulation is a 5% cream that you apply twice daily for about one month. During treatment, your skin will become increasingly red and inflamed, and you may notice patches appearing that you didn’t see before – these are subclinical lesions that the medication is bringing to the surface.^[14] The treatment can be temporarily disfiguring, with redness, crusting, and discomfort, but within about two weeks after you finish the treatment course, your skin typically heals and becomes smooth again. Other formulations include 2% and 1% solutions, as well as a newer 0.5% cream.

Imiquimod is another topical medication that works differently from 5-fluorouracil. Instead of directly killing abnormal cells, it stimulates your own immune system to recognize and attack them.^[9] This cream is typically applied several times per week for several weeks, depending on the specific formulation prescribed. Like 5-fluorouracil, imiquimod causes inflammation and irritation during treatment, which is actually a sign that your immune system is working to clear the damaged cells. The advantage of imiquimod is that it can treat visible and invisible lesions across a broader area.

Diclofenac gel is a non-steroidal anti-inflammatory drug that has been approved for treating actinic keratosis. It’s applied to the affected area twice daily for two to three months.^[14] While it tends to cause less dramatic inflammation compared to 5-fluorouracil or imiquimod, it also requires a longer treatment period to achieve results.

A newer option is tirbanibulin, which is a topical ointment that works by blocking the assembly of cellular structures needed for cell division.^[11] This medication is applied once daily for five consecutive days to a small treatment area. The shorter treatment course can be more convenient for some patients, though it still causes temporary skin irritation.

Photodynamic therapy, abbreviated as PDT, is a sophisticated treatment option that combines a light-sensitive medication with special light exposure. First, your doctor applies a cream containing delta-aminolevulinic acid to the affected skin area.^[14] This chemical is absorbed preferentially by abnormal cells. After the cream has been on your skin for a specific period, your doctor exposes the area to a special light source. When the light activates the medication, it produces a chemical reaction that destroys the abnormal cells.^[1] PDT is particularly useful for treating multiple or recurring lesions and can be effective for areas with widespread sun damage. The treatment can cause temporary burning sensations during light exposure, and your skin will be sensitive to sunlight for a period afterward.

The duration of treatment varies depending on which method is used. Cryotherapy and surgical procedures are typically one-time treatments, though you may need to return for follow-up visits to check healing or treat new lesions.^[9] Topical medications require consistent daily application for weeks to months. Your doctor will likely want to see you for regular check-ups after treatment to monitor for new patches and ensure that treated areas have healed properly.

Side effects are common with most treatments. Beyond the expected redness and irritation, some people experience scarring, changes in skin pigmentation (either lighter or darker than surrounding skin), or persistent texture changes.^[9] Surgical methods carry a small risk of infection and bleeding. With cryotherapy, temporary blistering is normal, but more significant blistering could occur. It’s important to discuss these potential effects with your healthcare provider before starting any treatment.

Innovative Approaches in Clinical Research

While standard treatments are effective for most people with actinic keratosis, researchers continue to investigate new therapeutic options through clinical trials. These studies explore different ways to remove precancerous lesions, prevent new ones from forming, and reduce the risk of progression to skin cancer. Clinical trials typically progress through three phases: Phase I focuses on determining whether a new treatment is safe and establishing appropriate dosing; Phase II evaluates whether the treatment actually works to clear actinic keratoses; and Phase III compares the new therapy against existing standard treatments to see if it offers advantages.^[13]

Some clinical trials are examining variations of existing treatments to improve effectiveness or reduce side effects. Researchers are testing different formulations of topical medications that might penetrate the skin more effectively or cause less irritation while maintaining therapeutic benefits. Others are exploring combinations of treatments used together or in sequence, hypothesizing that attacking actinic keratosis through multiple mechanisms simultaneously might produce better clearance rates than single-agent therapy.^[11]

Advanced photodynamic therapy protocols are being studied in various trial settings. Scientists are investigating different light-sensitizing agents beyond the standard aminolevulinic acid, as well as modified light sources and exposure times that might enhance the destruction of abnormal cells while minimizing damage to healthy surrounding tissue.^[11] Some studies are examining whether repeated PDT sessions at specific intervals might prevent the recurrence of actinic keratoses better than single treatments.

Immunotherapy approaches represent an area of active research interest. While imiquimod – which stimulates the immune system – is already an approved treatment, researchers are exploring other immune-modulating substances that might work through different pathways. These experimental therapies aim to train the immune system to recognize and eliminate cells with sun-induced DNA damage more effectively.^[11] Some trials are testing whether combining immune-stimulating treatments with other therapies produces synergistic effects.

Clinical trials for actinic keratosis are being conducted in multiple locations worldwide, including the United States, Europe, and other regions.^[13] Eligibility for these trials depends on various factors. Most require participants to have a confirmed diagnosis of actinic keratosis, often with a minimum number of lesions. Researchers typically exclude people who have recently used other actinic keratosis treatments, those with certain other skin conditions or active skin cancers in the treatment area, and individuals whose immune systems are significantly compromised. Each trial has specific inclusion and exclusion criteria designed to ensure participant safety and generate reliable data about the treatment being studied.

When preliminary results from clinical trials are reported, they often focus on what researchers call “clearance rates” – the percentage of lesions that completely disappear after treatment. Trials also track partial responses, where lesions improve but don’t completely vanish, and they monitor how long benefits last after treatment ends. Safety profiles are carefully documented, recording all side effects participants experience and their severity. While some early-phase trials have shown promising results with novel treatments, it’s important to remember that not all experimental therapies prove successful when tested in larger populations or over longer time periods.

Mechanisms of action for experimental treatments vary widely. Some target specific molecular pathways involved in the development of sun-damaged cells. Others work by enhancing the skin’s natural repair mechanisms or by selectively inducing cell death in abnormal keratinocytes while sparing healthy cells. Researchers are also investigating treatments that target the inflammation present in actinically damaged skin, based on evidence that chronic inflammation may contribute to the progression from precancerous lesions to invasive cancer.^[13]

Most Common Treatment Methods

• Cryotherapy (Freezing Treatment)
  • Application of liquid nitrogen to freeze and destroy abnormal cells
  • Quick office procedure taking only a few minutes
  • Area blisters and peels off over several days
  • Best for treating one or a few isolated patches
  • May cause temporary skin color changes or minor scarring
• Topical Chemotherapy
  • 5-Fluorouracil cream or solution applied at home for several weeks
  • Targets rapidly dividing abnormal cells
  • Causes temporary but significant skin inflammation and crusting
  • Can treat large areas with multiple lesions
  • Reveals and treats subclinical patches not visible before treatment
• Immune Response Modifiers
  • Imiquimod cream stimulates the body’s immune system to attack abnormal cells
  • Applied several times weekly for multiple weeks
  • Treats both visible and invisible lesions across broader skin areas
  • Causes inflammation as immune system responds to treatment
• Surgical Removal
  • Curettage and desiccation: scraping followed by heat or chemical application
  • Performed under local anesthetic in doctor’s office
  • Effective for removing specific individual lesions
  • Small risk of scarring or infection
• Photodynamic Therapy
  • Light-sensitive medication applied to skin followed by special light exposure
  • Medication preferentially absorbed by abnormal cells
  • Light activation triggers destruction of damaged cells
  • Useful for multiple or recurring lesions
  • Requires sun avoidance after treatment due to photosensitivity
• Non-Steroidal Anti-Inflammatory Treatment
  • Diclofenac gel applied twice daily for two to three months
  • Causes less dramatic inflammation than other topical treatments
  • Requires longer treatment duration
• Chemical Peels
  • Chemical solution applied to face causing top skin layers to peel off
  • New healthy skin regrows within several weeks
  • Used for treating facial actinic keratoses
• Laser Treatment
  • Focused laser beam vaporizes actinic keratosis lesions
  • Precise targeting of abnormal tissue
  • Can treat specific lesions or larger affected areas

Prevention and Long-Term Skin Health

Even after successful treatment of actinic keratosis, preventing new lesions is crucial for long-term skin health. The single most important preventive measure is protecting your skin from ultraviolet radiation. This means using broad-spectrum sunscreen with a sun protection factor of at least 30 every day, even when it’s cloudy, since UV rays penetrate through clouds.^[8] You should apply sunscreen to all exposed skin about 15 to 30 minutes before going outside and reapply every two hours, or more frequently if you’re swimming or sweating heavily.

Physical sun protection measures are equally important. Wearing wide-brimmed hats protects your face, scalp, and neck – all common sites for actinic keratosis.^[16] Long-sleeved shirts and long pants provide coverage for your arms and legs. Special sun-protective clothing is available that provides enhanced UV protection. Seeking shade during peak sun intensity hours, typically between 10 AM and 3 PM, significantly reduces your UV exposure.^[8]

Completely avoiding tanning beds and sunlamps is essential, as these artificial UV sources damage your skin just as the sun does. Regular self-examination of your skin helps you detect new actinic keratoses early, when they’re easiest to treat. You should check all sun-exposed areas monthly, feeling for rough or scaly patches and looking for new pink, red, or discolored spots.^[16] Annual skin examinations by a dermatologist are recommended for anyone who has had actinic keratoses, as healthcare providers can spot lesions you might miss and monitor your overall skin health.